CORRECTION article

Front. Oncol., 13 January 2023

Sec. Genitourinary Oncology

Volume 12 - 2022 | https://doi.org/10.3389/fonc.2022.1125641

Corrigendum: MRI radiomics predicts progression-free survival in prostate cancer

  • 1. Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China

  • 2. Department of Pharmaceuticals Diagnosis, GE Healthcare (China), Shanghai, China

  • 3. Department of Radiology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China

Article metrics

View details

1

Citations

1k

Views

611

Downloads

In the published article, there was an error in affiliation 3. Instead of “Department of Radiology, Inner Mongolia International Hospital, Hohhot, China”, it should be “Department of Radiology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

prostate cancer, radiomics, progression-free survival, magnetic resonance imaging, predictions

Citation

Jia Y, Quan S, Ren J, Wu H, Liu A, Gao Y, Hao F, Yang Z, Zhang T and Hu H (2023) Corrigendum: MRI radiomics predicts progression-free survival in prostate cancer. Front. Oncol. 12:1125641. doi: 10.3389/fonc.2022.1125641

Received

16 December 2022

Accepted

30 December 2022

Published

13 January 2023

Volume

12 - 2022

Edited and reviewed by

Matteo Ferro, European Institute of Oncology (IEO), Italy

Updates

Copyright

*Correspondence: Hui Wu, ; Aishi Liu,

This article was submitted to Genitourinary Oncology, a section of the journal Frontiers in Oncology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics